BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11748305)

  • 1. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
    Eng C; Brody LC; Wagner TM; Devilee P; Vijg J; Szabo C; Tavtigian SV; Nathanson KL; Ostrander E; Frank TS;
    J Med Genet; 2001 Dec; 38(12):824-33. PubMed ID: 11748305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review.
    Gerhardus A; Schleberger H; Schlegelberger B; Gadzicki D
    Eur J Hum Genet; 2007 Jun; 15(6):619-27. PubMed ID: 17342152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2.
    Choy YS; Dabora SL; Hall F; Ramesh V; Niida Y; Franz D; Kasprzyk-Obara J; Reeve MP; Kwiatkowski DJ
    Ann Hum Genet; 1999 Sep; 63(Pt 5):383-91. PubMed ID: 10735580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
    Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
    Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.
    Pilato B; De Summa S; Danza K; Papadimitriou S; Zaccagna P; Paradiso A; Tommasi S
    Mol Biotechnol; 2012 Sep; 52(1):8-15. PubMed ID: 22072316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).
    Geisler JP; Hatterman-Zogg MA; Rathe JA; Lallas TA; Kirby P; Buller RE
    Hum Mutat; 2001 Oct; 18(4):337-44. PubMed ID: 11668617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of the BRCA1 gene in Slovak patients.
    Tomka M; Sedlakova O; Reinerova M; Veselovska Z; Stevurková V; Bartosová Z; Zajac V
    Neoplasma; 2001; 48(6):451-5. PubMed ID: 11949836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols.
    Markoff A; Sormbroen H; Bogdanova N; Preisler-Adams S; Ganev V; Dworniczak B; Horst J
    Eur J Hum Genet; 1998; 6(2):145-50. PubMed ID: 9781059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene.
    Mátyás G; De Paepe A; Halliday D; Boileau C; Pals G; Steinmann B
    Hum Mutat; 2002 Apr; 19(4):443-56. PubMed ID: 11933199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohort.
    Herzog JS; Jancis EM; Liao S; Somlo G; Weitzel JN
    Hum Mutat; 2002 Jun; 19(6):656-63. PubMed ID: 12007222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers.
    Arnold N; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Kiechle M
    Hum Mutat; 1999; 14(4):333-9. PubMed ID: 10502781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC.
    Gross E; Arnold N; Goette J; Schwarz-Boeger U; Kiechle M
    Hum Genet; 1999; 105(1-2):72-8. PubMed ID: 10480358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
    Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
    Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
    Wagner T; Stoppa-Lyonnet D; Fleischmann E; Muhr D; Pagès S; Sandberg T; Caux V; Moeslinger R; Langbauer G; Borg A; Oefner P
    Genomics; 1999 Dec; 62(3):369-76. PubMed ID: 10644434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations.
    Taliani MR; Roberts SC; Dukek BA; Pruthi RK; Nichols WL; Heit JA
    Genet Test; 2001; 5(1):39-44. PubMed ID: 11336399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit.
    Campos B; Díez O; Cortés J; Domènech M; Pericay C; Alonso C; Baiget M
    Clin Chem Lab Med; 2001 May; 39(5):401-4. PubMed ID: 11434389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
    O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
    Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
    Bunn CF; Lintott CJ; Scott RS; George PM
    Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism.
    Jugessur A; Frost P; Andersen TI; Steine S; Lindblom A; Børresen-Dale AL; Eiken HG
    J Mol Med (Berl); 2000; 78(10):580-7. PubMed ID: 11199332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.